Company Search:
Advanced Search
Sponsored Links
BrightPath Biotherapeutics Co Ltd Company Snapshot
BrightPath Biotherapeutics Co Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares BrightPath Biotherapeutics Co Ltd with three other companies in this sector in Japan: Carna Biosciences Inc (2017 sales of 657.52 million Japanese Yen [US$6.17 million] ), AnGes Inc (365.18 million Japanese Yen [US$3.43 million] ), and 3-D Matrix Ltd (615.85 million Japanese Yen [US$5.78 million] of which 100% was Medical Products).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BrightPath Biotherapeutics Co Ltd
  Stock Performance Chart for BrightPath Biotherapeutics Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/9/2018): 764.00
(Figures in Japanese Yen)
1 Week -4.3%   13 Weeks 4.4%  
4 Weeks 16.6%   52 Weeks 19.2%  
BrightPath Biotherapeutics Co Ltd Key Data:
  Ticker: 4594 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 529,612,000
(Year Ending Jan 2018).
Employees: 37
  Currency: Japanese Yen Market Cap: 28,726,934,800
  Fiscal Yr Ends: March Shares Outstanding: 37,600,700
  Share Type: Common Closely Held Shares: 2,208,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.